Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AGN

Allergan

$154.23

-4.19 (-2.64%)

08:03
05/22/18
05/22
08:03
05/22/18
08:03
Hot Stocks
Allergan exercises option to acquire drug candidate AGN-241751 from Aptinyx »

Aptinyx announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Monday
AGN

Allergan

$158.42

-1.87 (-1.17%)

, HYG

iShares iBoxx $ High Yield Corporate Bond

$85.38

-0.095 (-0.11%)

08:45
05/21/18
05/21
08:45
05/21/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

AGN

Allergan

$158.42

-1.87 (-1.17%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.38

-0.095 (-0.11%)

TZA

Small Cap Bear 3x

$9.71

-0.04 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Friday
AMGN

Amgen

$174.63

0.9 (0.52%)

, NVS

Novartis

$77.15

-0.45 (-0.58%)

05:25
05/18/18
05/18
05:25
05/18/18
05:25
Recommendations
Amgen, Novartis, Teva, Allergan analyst commentary at Wells Fargo »

Amgen migraine drug price…

AMGN

Amgen

$174.63

0.9 (0.52%)

NVS

Novartis

$77.15

-0.45 (-0.58%)

TEVA

Teva

$21.11

0.22 (1.05%)

AGN

Allergan

$160.29

5.83 (3.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

  • 21

    May

  • 22

    May

  • 28

    May

  • 05

    Jun

  • 16

    Jun

Over a week ago
AGN

Allergan

$159.51

5.05 (3.27%)

16:02
05/17/18
05/17
16:02
05/17/18
16:02
Recommendations
Allergan analyst commentary at Wells Fargo »

Allergan declined to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$159.44

4.98 (3.22%)

15:57
05/17/18
05/17
15:57
05/17/18
15:57
Hot Stocks
FTC grants antitrust clearance for Tepper transaction with Allergan »

An early termination…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$65.35

1.14 (1.78%)

, KR

Kroger

$24.94

0.2 (0.81%)

06:47
05/17/18
05/17
06:47
05/17/18
06:47
Periodicals
Walgreen, Kroger, Albertsons, HEB sue Allergan over Restasis, Reuters reports »

U.S. retailers Walgreens…

WBA

Walgreens Boots Alliance

$65.35

1.14 (1.78%)

KR

Kroger

$24.94

0.2 (0.81%)

AGN

Allergan

$154.46

2.32 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    May

AGN

Allergan

$156.50

3.64 (2.38%)

, EOLS

Evolus

$10.07

-4.58 (-31.26%)

10:09
05/16/18
05/16
10:09
05/16/18
10:09
Recommendations
Allergan, Evolus analyst commentary at Wells Fargo »

Evolus CRL good news for…

AGN

Allergan

$156.50

3.64 (2.38%)

EOLS

Evolus

$10.07

-4.58 (-31.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 31

    May

EOLS

Evolus

$14.65

0.97 (7.09%)

09:00
05/16/18
05/16
09:00
05/16/18
09:00
Hot Stocks
Breaking Hot Stocks news story on Evolus »

Evolus Inc trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 31

    May

EOLS

Evolus

$14.65

0.97 (7.09%)

08:57
05/16/18
05/16
08:57
05/16/18
08:57
Hot Stocks
Evolus receives FDA Complete Response Letter for DWP-450 »

Evolus announced updates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 31

    May

EOLS

Evolus

$14.65

0.97 (7.09%)

07:53
05/16/18
05/16
07:53
05/16/18
07:53
Hot Stocks
Breaking Hot Stocks news story on Evolus »

Evolus Inc trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 31

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.